LABTLakewood-Amedex Biotherapeutics Inc.
$4.02
$0.37
(10.14%)
Mkt Cap$6.37M
Vol363,156.00
Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin Compounds Being Developed for High-Need Antimicrobial Infections
Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin Compounds Being Developed for High-Need Antimicrobial Infections Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin Compounds Being Developed for...
PR Newswire
Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum
Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum PR Newswire SARASOTA, Fla., June 16, 2026 SARASOTA, Fla., June 16, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc...
PR Newswire
Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers
Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers PR Newswire SARASOTA, Fla., May 27, 2026 Patent portfolio now includes 71...
PR Newswire
Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers
Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers Lakewood-Amedex Biotherapeutics Announces Positive Data for the...
PR Newswire
Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for Phase 2 Clinical Trial of Nu-3
Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for Phase 2 Clinical Trial of Nu-3 Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for...
PR Newswire
Promising Penny Stocks To Watch Today - May 3rd
Esperion Therapeutics, SOBR Safe, JetBlue Airways, BigBear.ai, Lakewood-Amedex Biotherapeutics, Beyond Meat, and Direxion Daily AMD Bear 1X Shares are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small public companiesc...
MarketBeat
Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data for Lead Candidate Targeting Infected Diabetic Foot Ulcers
Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data for Lead Candidate Targeting Infected Diabetic Foot Ulcers Lakewood-Amedex Biotherapeutics Announces Positive...
PR Newswire
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors PR Newswire SARASOTA, Fla...
PR Newswire
Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol "LABT"
Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol 'LABT' Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the...
PR Newswire
<
1
2
...
>
Advertisement|Remove ads.
Latest LABT News
ViewLakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin Compounds Being Developed for High-Need Antimicrobial Infections
PR Newswire
Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum
PR Newswire
Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers
PR Newswire
Advertisement|Remove ads.